Results 161 to 170 of about 88,161 (270)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

open access: yesThe Prostate, Volume 86, Issue 3, Page 338-348, February 15, 2026.
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez   +8 more
wiley   +1 more source

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

open access: yesThe Prostate, Volume 86, Issue 3, Page 365-371, February 15, 2026.
ABSTRACT Introduction Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long‐term survival outcomes remain unclear. This study evaluates the durability of response following neoadjuvant ADT plus enzalutamide before robot ...
Braden Millan   +9 more
wiley   +1 more source

MP86-12 Psychological distress in patients undergoing surgery for urological cancer. A prospective single centre cross-sectional study [PDF]

open access: yes, 2017
Camps, Nuria   +6 more
core   +1 more source

Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy. [PDF]

open access: yesBJU Int
Marmiroli A   +23 more
europepmc   +1 more source

PSMA PET‐directed radiotherapy for prostate cancer: From precision planning to future innovations

open access: yesVIEW, Volume 7, Issue 1, February 2026.
Prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) imaging enables highly sensitive detection of prostate cancer recurrence and precise lesion mapping. This review summarizes current evidence and emerging applications of PSMA PET in radiotherapy, including diagnostic staging, target delineation, adaptive planning, and outcome ...
Wenpeng Huang   +7 more
wiley   +1 more source

Comparative efficacy of combination therapy including regenerative therapies versus monotherapy for erectile dysfunction: A systematic review and meta‐analysis

open access: yesAndrology, Volume 14, Issue 2, Page 358-367, February 2026.
Abstract Background and objective The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.
Alberto Quistini   +12 more
wiley   +1 more source

Rectal cancer following radiotherapy for prostate cancer: A propensity‐matched analysis

open access: yesColorectal Disease, Volume 28, Issue 2, February 2026.
Abstract Aim Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized.
M. Goldenshluger   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy